BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 28103952)

  • 1. The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk.
    Kindinger LM; Bennett PR; Lee YS; Marchesi JR; Smith A; Cacciatore S; Holmes E; Nicholson JK; Teoh TG; MacIntyre DA
    Microbiome; 2017 Jan; 5(1):6. PubMed ID: 28103952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal bacterial load in the second trimester is associated with early preterm birth recurrence: a nested case-control study.
    Goodfellow L; Verwijs MC; Care A; Sharp A; Ivandic J; Poljak B; Roberts D; Bronowski C; Gill AC; Darby AC; Alfirevic A; Muller-Myhsok B; Alfirevic Z; van de Wijgert J
    BJOG; 2021 Dec; 128(13):2061-2072. PubMed ID: 34139060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical pessary and cerclage placement for preterm birth prevention and cervicovaginal microbiome changes.
    Vargas M; Yañez F; Elias A; Bernabeu A; Goya M; Xie Z; Farrás A; Sánchez O; Soler Z; Blasquez C; Valle L; Olivella A; Muñoz B; Brik M; Carreras E; Manichanh C
    Acta Obstet Gynecol Scand; 2022 Dec; 101(12):1403-1413. PubMed ID: 36168933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervicovaginal microbial communities deficient in Lactobacillus species are associated with second trimester short cervix.
    Gerson KD; McCarthy C; Elovitz MA; Ravel J; Sammel MD; Burris HH
    Am J Obstet Gynecol; 2020 May; 222(5):491.e1-491.e8. PubMed ID: 31816307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal Biomarkers That Predict Cervical Length and Dominant Bacteria in the Vaginal Microbiomes of Pregnant Women.
    Witkin SS; Moron AF; Ridenhour BJ; Minis E; Hatanaka A; Sarmento SGP; Franca MS; Carvalho FHC; Hamamoto TK; Mattar R; Sabino E; Linhares IM; Rudge MVC; Forney LJ
    mBio; 2019 Oct; 10(5):. PubMed ID: 31641087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal microbiome in early pregnancy and subsequent risk of spontaneous preterm birth: a case-control study.
    Tabatabaei N; Eren AM; Barreiro LB; Yotova V; Dumaine A; Allard C; Fraser WD
    BJOG; 2019 Feb; 126(3):349-358. PubMed ID: 29791775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix.
    Alfirevic Z; Owen J; Carreras Moratonas E; Sharp AN; Szychowski JM; Goya M
    Ultrasound Obstet Gynecol; 2013 Feb; 41(2):146-51. PubMed ID: 22991337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options and recommendations to reduce preterm births in women with short cervix.
    Slager J; Lynne S
    J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pessary Compared With Vaginal Progesterone for the Prevention of Preterm Birth in Women With Twin Pregnancies and Cervical Length Less Than 38 mm: A Randomized Controlled Trial.
    Dang VQ; Nguyen LK; Pham TD; He YTN; Vu KN; Phan MTN; Le TQ; Le CH; Vuong LN; Mol BW
    Obstet Gynecol; 2019 Mar; 133(3):459-467. PubMed ID: 30741812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical pessary plus vaginal progesterone versus long-term tocolysis for the prevention of preterm birth: An observational retrospective study.
    Tajima M; Yanazume S; Orita Y; Tazaki Y; Shinya M; Kobayashi H
    Int J Gynaecol Obstet; 2020 Aug; 150(2):206-212. PubMed ID: 32282943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening.
    Enakpene CA; DiGiovanni L; Jones TN; Marshalla M; Mastrogiannis D; Della Torre M
    Am J Obstet Gynecol; 2018 Oct; 219(4):397.e1-397.e10. PubMed ID: 30017683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.
    Hassan SS; Romero R; Vidyadhari D; Fusey S; Baxter JK; Khandelwal M; Vijayaraghavan J; Trivedi Y; Soma-Pillay P; Sambarey P; Dayal A; Potapov V; O'Brien J; Astakhov V; Yuzko O; Kinzler W; Dattel B; Sehdev H; Mazheika L; Manchulenko D; Gervasi MT; Sullivan L; Conde-Agudelo A; Phillips JA; Creasy GW;
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):18-31. PubMed ID: 21472815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length: A Randomized Clinical Trial.
    Saccone G; Maruotti GM; Giudicepietro A; Martinelli P;
    JAMA; 2017 Dec; 318(23):2317-2324. PubMed ID: 29260226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial.
    van Zijl MD; Koullali B; Naaktgeboren CA; Schuit E; Bekedam DJ; Moll E; Oudijk MA; van Baal WM; de Boer MA; Visser H; van Drongelen J; van de Made FW; Vollebregt KC; Muller MA; Bekker MN; Brons JTJ; Sueters M; Langenveld J; Franssen MT; Schuitemaker NW; van Beek E; Scheepers HCJ; de Boer K; Tepe EM; Huisjes AJM; Hooker AB; Verheijen ECJ; Papatsonis DN; Mol BWJ; Kazemier BM; Pajkrt E
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):284. PubMed ID: 28870155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Vaginal Microbial Signatures of Preterm Birth Delivery in Indian Women.
    Kumar S; Kumari N; Talukdar D; Kothidar A; Sarkar M; Mehta O; Kshetrapal P; Wadhwa N; Thiruvengadam R; Desiraju BK; Nair GB; Bhatnagar S; Mukherjee S; Das B;
    Front Cell Infect Microbiol; 2021; 11():622474. PubMed ID: 34094994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal progesterone combined with cervical pessary: A chance for pregnancies at risk for preterm birth?
    Stricker N; Timmesfeld N; Kyvernitakis I; Goerges J; Arabin B
    Am J Obstet Gynecol; 2016 Jun; 214(6):739.e1-739.e10. PubMed ID: 26692180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should phenotype of previous preterm birth influence management of women with short cervix in subsequent pregnancy? Comparison of vaginal progesterone and Arabin pessary.
    Care A; Muller-Myhsok B; Olearo E; Todros T; Caradeux J; Goya M; Palacio M; Carreras E; Alfirevic Z
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):529-534. PubMed ID: 29920812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique Insights in the Cervicovaginal Lactobacillus iners and L. crispatus Proteomes and Their Associations with Microbiota Dysbiosis.
    Borgdorff H; Armstrong SD; Tytgat HL; Xia D; Ndayisaba GF; Wastling JM; van de Wijgert JH
    PLoS One; 2016; 11(3):e0150767. PubMed ID: 26963809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical pessary vs vaginal progesterone for prevention of preterm birth in women with twin pregnancy and short cervix: economic analysis following randomized controlled trial.
    Le KD; Nguyen LK; Nguyen LTM; Mol BWJ; Dang VQ
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):339-347. PubMed ID: 31432562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial on the use of pessary plus progesterone to prevent preterm birth in women with short cervical length (P5 trial).
    Pacagnella RC; Mol BW; Borovac-Pinheiro A; Passini R; Nomura ML; Andrade KC; Ellovitch N; Fernandes KG; Bortoletto TG; Pereira CM; Miele MJ; França MS; Cecatti JG;
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):442. PubMed ID: 31775669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.